Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 6/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.32 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.31 |
| ▸ | BUB1 | O43683 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953141 | 0.93 | IL17A (0.34) | IL17A | |
| SCHEMBL30952959 | 0.92 | IL17A (0.32) | IL17ACDK2CCNE1GSK3BLMNA | |
| SCHEMBL30953504 | 0.86 | NAMPT (0.32) | IL17A | |
| SCHEMBL30953102 | 0.86 | — | — | |
| SCHEMBL30953039 | 0.86 | IL17A (0.38) | IL17A | |
| SCHEMBL30952938 | 0.85 | IL17A (0.45) | IL17ACDK2CCNE1GSK3BF11 | |
| SCHEMBL30953158 | 0.85 | IL17A (0.37) | IL17A | |
| SCHEMBL30953152 | 0.85 | IL17A (0.35) | IL17A | |
| SCHEMBL30953010 | 0.85 | IL17A (0.35) | IL17A | |
| SCHEMBL30952925 | 0.85 | IL17A (0.33) | IL17A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |